Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the efficacy of ciclesonide versus budesonide on lung
function, symptoms and use of rescue medication in patients with asthma. Ciclesonide and
budesonide will be inhaled once daily at one dose level each. The study duration consists of
a baseline period (1 to 4 weeks) and a treatment period (12 weeks). The study will provide
further data on safety and tolerability of ciclesonide.